DeepMed Research

IPN-01194

Generic Name: IPN-01194

Clinical Trials

A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours

Phase 1

Recruiting

Conditions: Pancreatic Ductal Adenocarcinoma
Colorectal Cancer
Solid Tumor
Melanoma
Head and Neck Squamous Cell Carcinoma

Interventions: Drug: IPN01194

First Posted Date: 2024-03-12

Last Posted Date: 2025-05-01

Lead Sponsor: Ipsen

Target Recruit Count: 220

Registration Number: NCT06305247

Locations: 🇫🇷
Centre Léon Bérard - Lyon, Lyon, France
🇫🇷
Paris Saint-Louis, Paris, France
🇺🇸
The Angeles Clinic and Research Institute - California, Los Angeles, California, United States

and more 9 locations

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy